Department of Gastroenterology, Kanazawa University, Kanazawa, Ishikawa, Japan.
Hepatol Res. 2013 Jan;43(1):44-50. doi: 10.1111/j.1872-034X.2012.01029.x. Epub 2012 May 14.
The main methods of treatment for hepatocellular carcinoma (HCC) in Japan are hepatic resection, radiofrequency ablation (RFA) and transcatheter arterial chemoembolization (TACE). Meticulous follow up is then undertaken to check for recurrence, which is treated using repeated RFA or TACE. Hepatic arterial infusion chemotherapy has been introduced as treatment for advanced HCC, and the molecular-targeted drug sorafenib is also now available. Rigorous medical care using these treatment methods and early diagnosis mean that the prognosis for HCC in Japan is the best in the world. This paper reviews the treatment strategies for HCC in Japan.
日本肝细胞癌（HCC）的主要治疗方法是肝切除术、射频消融（RFA）和经导管动脉化疗栓塞（TACE）。然后进行细致的随访以检查复发情况，复发时采用重复 RFA 或 TACE 进行治疗。肝动脉灌注化疗已被引入治疗晚期 HCC，现在也有分子靶向药物索拉非尼。使用这些治疗方法和早期诊断的严格医疗意味着日本 HCC 的预后是世界上最好的。本文综述了日本 HCC 的治疗策略。
